E-ISSN:2456-3110

Review Article

Anxiety

Journal of Ayurveda and Integrated Medical Sciences

2022 Volume 7 Number 2 March
Publisherwww.maharshicharaka.in

Evidence Based Explanation of the Quote “Vishaado Roga Vardhananam”- A Review

Monika.1*
DOI:

1* Monika, Assistant Professor, Department of Kaumarbhritya, Divya Jyoti Ayurvedic Medical College and Hospital, Modinagar, Ghaziabad, Uttar Pradesh, India.

Acharya Charaka has given a quote as “Vishaado Roga Vardhananam” in “Yajyha Purushiya Adhyaya”. Vichada is correlated with generalized anxiety disorder and depression. This quotation means that depression is a leading factor in aggravation of any disease. Depression is a common problem which alters quality of life. It is a major cause of burden of disease worldwide. This paper is a collection of various previous researches which focusses on scientific explanation of this quotation. Depression alters the normal activity of hypothalamic-pituitary-adrenal (HPA) axis. Epigenetic mechanism of DNA methylation is associated with depression. Anxiety or depression can cause alteration in normal functioning of metabolic, neurological, immunological and endocrinal activities of the body. Depression can strengthen the risk of development of various cardiac, respiratory and GIT disorders. Stress or high levels of anxiety or depression during pregnancy lead to long term effects in children like cognitive impairment and developmental disorders. Anxiety or both anxiety and depression are the risk factors for conversion of glaucoma suspects to glaucoma sufferers over a period of time. Childhood depression or anxiety alters quality of life and two to five times increases the risk of suicidal attempts in late childhood or adulthood. This gives an approach towards treatment of any disease which must be focussed on both the physical as well as psychological aspects.

Keywords: Anxiety, Charaka, Depression, Roga, Vishaada, Ayurveda

Corresponding Author How to Cite this Article To Browse
Monika, Assistant Professor, Department of Kaumarbhritya, Divya Jyoti Ayurvedic Medical College and Hospital, Modinagar, Ghaziabad, Uttar Pradesh, India.
Email:
Monika, Evidence Based Explanation of the Quote “Vishaado Roga Vardhananam”- A Review. J Ayu Int Med Sci. 2022;7(2):101-106.
Available From
https://jaims.in/jaims/article/view/1735

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2022-02-03 2022-02-05 2022-02-12 2022-02-19 2022-02-26
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
Nil Nil Yes 18%

© 2022by Monikaand Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Introduction

Ayurveda is an ancient and holistic system of medicine. Various mental disorders and psychological disorders are well explained in Ayurveda texts. Psychological conditions like Kama, Krodha, Shoka, Bhaya, Moorcha, Vishaada etc are described in Ayurveda caused by Manasa Doshas, i.e., Rajas and Tamas.[1] The term Vishaada is described as a disease aggravating factor by Acharya Charaka in “Agrya Sangraha” as “Vishaado Roga Vardhananam”.[2] Various Commentators have given explanation of the term Vishaada. As per chakrapani “Vishaado Anushtheyoatmana Ashaktatajananam” it is a feeling of incompetence to accomplish a work. According to Dalhana “Asiddhibhayat Dvividheshu Karmeshu Apravritti Vishaada” it is inability of the mind and body to function properly due to fear of failure. As per Gangadhara “Vishaada Sarvada Manah Khedah” it is a continuous feeling of sadness and According to Arundatta “Vishadatvam Dukhkhitatvam” it is feeling of sorrowfulness. The term Vishaada is comparable with “Generalized Anxiety disorder”.[3] Generalised anxiety disorder is recognised by symptoms like irritability, feeling of threat, restlessness, disturbance of sleep, palpitations, dryness of mouth, sweating and unfocused worry and anxiety.[4] Vishaada can also be correlated with Depression.[5] Major depression is a common problem that severely diminishes psychosocial functioning which further alters quality of life. In 2008 WHO announced depression at rank third as a cause of burden of disease worldwide and it will be ranked first by 2030.[6]

The word Roga is synonym of the term Vyadhi which is defined by Acharya Sushruta as “Tadduhkha Samyogah Vyadhayah”[7] which means pain of the soul, and this pain is indicator of a disease. Hence, condition with painful sensation is considered as a disease.

Meaning of the word “Vardhana” is “causing to increase” or “strengthening”[8]. So, the quote “Vishaado Roga Vardhananam” indicates that anxiety/depression is a progressive or risk factor for development of a disease. It is need of this era to focus on psychology of a person, moreover this fact is hidden in the above said quotation which need to be explored to the society. So, the present article is focussed on collection of various previous researches to give scientific recognition to the above mentioned quote.

Aim

To prove the quote “Vishaado Roga Vardhananam” by referring various previous researches.

Materials and Methods

Various Ayurveda classics were sighted for the study. Previous research works, books, articles and various journals were searched out from Data bases like pub med, Google Scholar and Ayush portal.

Results

Depression alters the normal activity of hypothalamic-pituitary-adrenal (HPA) axis[9]. Anxiety or depression are considered as negative emotions, declared as risk factors for physical illness and increases the rate of development of cardiac disorders, respiratory disorders and GIT disorders[10-14]. Depression is a risk factor for Type 2 diabetes mellitus[15]. Depression is directly or indirectly related with aggravation of diseases like Alzheimer’s disease, stroke, epilepsy and cancer[16]. Anxiety and depression are risk factors for the development of Oral lichen planus[17]. There is a definite association between depression and DED (Dry eye disease)[18]. Hyperphagia is seen in patients with depression which may alters normal functioning of liver, alters liver biochemistry, elevates liver enzymes and impairs hepatic blood flow[19].

Persons having depression or anxiety shows symptoms of Persons who suffer from depression have reduced immune response to varicella zoster vaccine.[20]

Studies shows that psychological stress is associated with activation of Herpes simplex virus-2[21] Depressed Adolescents and adults are more likely to engage in risky sexual behaviour which further enhances risk for diseases like HIV, herpes simplex virus type 2 and other sexually transmitted diseases.[22]  Pathogenesis of symptoms like pain, fatigue and cognitive impairment is related to somatic disease as well as to mood depression. Hence, management must be focus on psychopharmacological aspect.[23]

Anaemia like paleness, fatigue, dizziness, shortness of breath during exertion, increased heart beat in resting state and heart fluttering.[24]


Anxiety disorders are associated with exaggerated changes in fear neurocircuitry response in the amygdala and impairment in regulatory processes by the prefrontal cortex (PFC) and hippocampus which further causes structural degeneration in prefrontal cortex and hippocampus. Hence, responsible for inhibition of PFC and hippocampus control over stress. It was studied that antidepressant medicines, cognitive behavioural therapies and exercise may be helpful in reversing the damage in the brain.[25] Depression, anxiety and cognitive impairment are related with reduced life expectancy and quality of life which further increases the rate of hospitalization and healthcare expenditure.[26] One of the previous retrospective studies concludes that anxiety disorders of adolescents are associated with premature withdrawal from schools which impairs their educational achievement.[27] In a study, sample consisted of 395 haemodialysis patients were assessed for the level of depression and anxiety along with quality of life by using HADs scale and Missoula-VITAS Quality of Life Index (MVQOLI), Out of 395 patients, 47.8% had high anxiety levels and 38.2% had high level of depression and it was found that patients with low levels of anxiety or depression had better quality of life. It was concluded that early recognition and management of depression is a matter of concern in haemodialysis patients.[28] Stress or high levels of anxiety or depression during pregnancy lead to long term effects in children like cognitive impairment and developmental disorders.[29] Progression of disability was seen in older women suffering from anxiety.[30]  In a retrospective cohort study, it was found that anxiety or both anxiety and depression are the risk factors for conversion of glaucoma suspects to glaucoma sufferers over a period of time.[31] In a meta-analysis it was concluded that “post-MI depression was significantly associated with all-cause mortality (odds ratio [OR], fixed 2.38; 95% confidence interval [CI], 1.76-3.22; p <.00001) and cardiac mortality (OR fixed, 2.59; 95% CI, 1.77-3.77; p <.00001)”. Patients of Myocardial Infarction (MI) having depression are at risk of development of new cardiovascular events.[32] Depression is a predictor of cardiac morbidity and mortality of a person. Depression present in a patient within 30 days of Acute coronary syndrome (ACS) is strongly related to morbidity and mortality but with a history of depression prior to ACS without current occurrence

was not linked with adverse effects.[33] Depression can cause alteration in immune mechanism of the body which results in abnormalities of expression of proinflammatory cytokines. These abnormalities influence central nervous system and contribute in pathophysiology of the disorder.[34] Exposure to adverse childhood experiences like death of parents, divorce of parents, separation from parents, physical abuse, violence, neglect, life threatening physical illness or extreme socio-economic problems can result in depression, anxiety disorder or post-traumatic stress disorder (PTSD).[35] Early-stage adverse exposure can cause two to five times increase in the rate of suicidal attempts in late childhood, adolescent age or adulthood.[36] Activation of hypothalamic-pituitary-adrenal (HPA) axis in depressive patients probably alters the immune system which can further contribute in the development of cancer.[37] In studies it was shown that the epigenetic mechanism of DNA methylation is associated with depression.[38-40]

Discussion

Ayurveda is a science based on ancient Indian philosophy. It can appropriately be called as “The science of Living”. Ayurveda has been in existence since the beginning of time.  Therefore in Charak Samhita, Ayurveda has been described as Shashvata (eternal).  The Charak Samhita is an ancient Indian Ayurvedic text on internal medicine written by Acharya Charak. Acharya Charak has a great contribution towards Ayurved by giving such great literature. Acharya Charak has been referred as the Father of non-surgical Ayurvedic Indian Medicine. His principles, diagnosis and treatment retain their potency and truth even after a couple of millennia. Therefore Charak Samhita is considered to be the most ancient and authoritative work on Ayurveda available today. This Samhita is useful for those who want to improve their health and happiness. It is mentioned that a Vaidya who has studied many others book but not the Charak Samhita then he will be criticize among the Vaidyas who have studied the Charak Samhita. In Siddhisthana, Acharya Charak specifically mentioned that whatever is mentioned in this Samhita is available elsewhere but things which are not mentioned here are not to be found anywhere else.[41] This reference proves the importance of Charak Samhita in the field of Ayurveda.  Therefore, it becomes necessary to study and understand the


special features mentioned Charak Samhita. This review article deals with the historical study of such a great personality of Ayurveda and his special contribution in the progress of Ayurvedic science.

The Charaka Samhita is a huge treatise on ayurveda written in Sanskrit language. Concepts mentioned in Charaka Samhita are true and retain their potency even in this era of 21st century. In the chapter “Yajyha purushiye adhyaye” Acharya Charaka explained the prominent entities among the drugs and other items used for various actions, these are explained in single sentence quotations. Among various quotes, this article mainly focussed on the quote “Vishaado Roga Vardhananam”. Various definitions of the term Vishaada matches with important signs of depression. Results shown that psychology has an impact on physical body. Anxiety or depression can cause alteration in normal functioning of metabolic, neurological, immunological and endocrinal activities of the body. It can affect functioning of major organs like heart, liver and kidney. It can cause cancer like serious problems. Childhood depression or anxiety alters quality of life and two to five times increases the risk of suicidal attempts in late childhood or adulthood. Prenatal stress can activate the HPA stress response and increase production of corticotropin-releasing hormone (CRH) which stimulate the production of inflammatory cytokines during gestation.

After studying various peptides and receptors, it was shown that only 2 percent of neuronal communications in our body are electrical, across a synapse rather "the brain is a bag of hormones." These hormones affect every aspect of body and mind. A lot of memories are stored in the body with changes in these receptors at cellular level.  "The body" "Is the unconscious mind" said by Candace B. Pert, A Scribner.[42] Hence, a lot of evidences proves that psychological imbalance can create/enhance a physiological imbalance.

Conclusion

It is concluded that depression or anxiety is a contributing factor in aggravation of a disease. A single quote of Acharya Charaka “Vishaado Roga Vardhananam” can become a boon for the health industry which proves correlation between occurrence of a disease and impact of emotions on it.  So, treatment of each and every disease

must be focussed on both physiology and psychology of the patient. Various antidepressant therapies with counselling are additional management tools for regression of a disease. This opens the way for third decade research which must be focussed on preventive aspects of diseases through various mindfulness and soulfulness activities.

Reference

1. Agnivesha. “Charaka Samhita” revised by Charaka and Dridhbala with “Ayurveda Dipika‟commentary by Chakrapanidatta, edited by Vaidya Yadav ji Trikam ji Acharya, Chaukhambha Surbharti Prakashan,Varanasi, reprint, Sutrasthana, 2008; 1/57: 16.

2. Agnivesha. “Charaka Samhita” revised by Charaka and Dridhbala with “Ayurveda Dipika‟commentary by Chakrapanidatta,edited by Vaidya Yadavji Trikamji Acharya, Chaukhambha Surbharti Prakashan,Varanasi, reprint Sutrasthana, 2008; 25/40: 132.

3. Khyati et al. A Clinical Interpretation of the Term Vishaada W.S.R.To Generalized Anxiety Disorder, World Journal of Pharmacy and Pharmaceutical Sciences, Aug 2016; 5(9): 978-989.

4. Peter Tyrer, David Baldwin. Generalised anxiety disorder,The Lancet,Volume 368, Issue 9553, 2006, Pages 2156-2166.

5. Jabeen G Shaikh, Shrikant G Deshmukh. Vishada (Depression) in Ayurveda: A Literary Review. International Journal of Ayurveda. Jan 2020 , Vol 05, Issue 01|01-05.

6. Gin S Malhi, J John Mann. Depression. The Lancet. Volume 392, Issue 10161,2018,Pages 2299-2312.

7. Sushruta. “Sushruta Samhita” K.R Srikantha Murthy, “Illustrated Sushruta Samhita”, Chaukhambha Orientalia, Varanasi, Reprint edition, Vol 1, Sutrasthana, Chapter 1/23.

8. https://sanskritdictionary.com (accessed on 10/3/2022)

9. Voinov B, Richie WD, Bailey RK. Depression and chronic diseases: it is time for a synergistic mental health and primary care approach. Prim Care Companion CNS Disord. 2013; 15:2


10. Bailey PH. The dyspnea-anxiety-dyspnea cycle–COPD patients’ stories of breathlessness: “It’s scary/when you can’t breathe”. Qual. Health Res. 2004, 14, 760–778.

11. DeJean D, Giacomini M, Vanstone M, Brundisini F. Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess. Ser 2013,13, 1–33.

12. Suls J, Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psychol. Bull. 2005,131, 260–300.

13. Goldney, R. D., Ruffin, R., Fisher, L. J. & Wilson, D. H. Asthma symptoms associated with depression and lower quality of life: a population survey. Med. J. Aust. 2003,178, 437–441.

14. Mayer EA, Craske M, Naliboff BD. Depression, anxiety, and the gastrointestinal system. J Clin Psychiatry. 2001;62 Suppl 8:28-36.

15. Mezuk, B.; Eaton, W.W.; Albrecht, S.; Golden, S.H. Depression and type 2 diabetes over the lifespan: A meta-analysis. Diabetes Care 2008, 31, 2383–2390.

16. Abdel-Bakky MS, Amin E, Faris TM, Abdellatif AAH. Mental depression: Relation to different disease status, newer treatments and its association with COVID-19 pandemic (Review). Mol Med Rep. 2021 Dec;24(6):839.

17. Arcía-Pola Vallejo M, J, Huerta G, Cerero R, Seoane J, M: Anxiety and Depression as Risk Factors for Oral Lichen planus. Dermatology 2001; 203:303-307.

18. Nesime Setge Tiskaoglu, Alper Yazıcı, Tunay Karlıdere, Esin Sari, Elif Yilmaz Oguz, Musa Musaoglu, Seyda Aslan & Sıtkı Samet Ermiş (2017) Dry Eye Disease in Patients with Newly Diagnosed Depressive Disorder, Current Eye Research, 42:5, 672-676.

19. Elwing, J.E.; Lustman, P.J.; Wang, H.L.; Clouse, R.E. Depression, anxiety, and nonalcoholic steatohepatitis. Psychosom. Med. 2006, 68, 563–569.

20. Irwin MR, Levin MJ, Carillo C, Olmstead R, Lucko A, Lang N, et al. Major depressive disorder and immunity to varicella-zoster virus in the elderly. Brain Behav Immun. 2011; 25:759-66.

21. Cohen F, Kermeny ME, Kearney KA, Zegans LS, Neuhaus JM, Conant MA. Persistent stress as a predictor of genital herpes recurrence. Arch Intern Med. 1999; 159:2430-6

22. Scourfield A, Zheng J, Chinthapalli S, Waters L, Martin T, Mandalia S, Nelson M. Discontinuation of Atripla® as first-line therapy in HIV-1 infected individuals. AIDS. 2012; 26:1399-401.

23. Torta R, Pennazio F, Ieraci V. Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management. Reumatismo. 2014 Jun 6;66(1):92-7.

24. Lever-van Milligen BA, Vogelzangs N, Smit JH, Penninx BW. Hemoglobin levels in persons with depressive and/or anxiety disorders. J Psychosom Res. 2014 Apr;76(4):317-21.

25. Mah Linda, Szabuniewicz, Claudia, Fiocco, Alexandra j; Can anxiety damage the brain? Current Opinion in Psychiatry, Volume 29, Number 1, January 2016, pp. 56-63(8).

26. Angermann, C.E., Ertl, G. Depression, Anxiety, and Cognitive Impairment. Curr Heart Fail Rep, 2018, 15, 398–410.

27. Michael Van Ameringen, Catherine Mancini, Peter Farvolden,The impact of anxiety disorders on educational achievement, Journal of Anxiety Disorders,Volume 17, Issue 5, 2003, Pages 561-571.

28. Vasilopoulou C, Bourtsi E, Giaple S, Koutelekos I, Theofilou P, Polikandrioti M. The Impact of Anxiety and Depression on the Quality of Life of Hemodialysis Patients. Glob J Health Sci. 2015;8(1):45-55.

29. Stein, A., Pearson, R.M., Goodman, S.H., Rapa, E., Rahman, A., McCallum, M., Howard, L.M. & Pariante, C.M. (2014) Effects of perinatal mental disorders on the fetus and child. Lancet 384, 1800–1819.

30. Brenes, G.A., Guralnik, J.M., Williamson, J.D., Fried, L.P., Simpson, C., Simonsick, E.M. and Penninx, B.W.J.H.; The Influence of Anxiety on the Progression of Disability. Journal of the American Geriatrics Society, 2005; 53: 34-39.

31. Berchuck S, Jammal A, Mukherjee S, et al, Impact of anxiety and depression on progression to glaucoma among glaucoma suspects, British Journal of Ophthalmology 2021;105:1244-1249.


32. van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen DJ, van den Brink RH, van den Berg MP. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med. 2004 Nov-Dec;66(6):814-22

33. Leung YW, Flora DB, Gravely S, Irvine J, Carney RM, Grace SL. The impact of premorbid and postmorbid depression onset on mortality and cardiac morbidity among patients with coronary heart disease: meta-analysis. Psychosomatic Medicine. 2012;74(8):786–801

34. Michael R. Irwin, Andrew H. Miller, Depressive disorders and immunity: 20 years of progress and discovery, Brain, Behavior, and Immunity, Volume 21, Issue 4, 2007, Pages 374-383.

35. Chapman DP, Whitfield CL, Felitti VJ, Dube SR, Edwards VJ, Anda RF. Adverse childhood experiences and the risk of depressive disorders in adulthood. J Affect Disord (2004) 82:217–25.

36. Dube SR, Anda RF, Felitti VJ, Chapman DP, Williamson DF, Giles WH. Childhood abuse, household dysfunction, and the risk of attempted suicide throughout the life span: findings from the Adverse Childhood Experiences Study. JAMA (2001) 286:3089–96.

37. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004; 5:617–625.

38. Bakusic J, Schaufeli W, Claes S, Godderis L. Stress, burnout and depression: A systematic review on DNA methylation mechanisms. J Psychosom Res. 2017; 92:34–44.

39. Li M, D’Arcy C, Li X, Zhang T, Joober R, Meng X. What do DNA methylation studies tell us about depression? A systematic review. Transl Psychiatry. 2019; 9:68.

40. Lockwood LE, Su S, Youssef NA. The role of epigenetics in depression and suicide: A platform for gene–environment interactions. Psychiatry Res. 2015; 228:235–242.

41. Agnivesha, “Charaka Samhita” revised by Charaka and Dridhbala with “Ayurveda Dipika‟commentary by Chakrapanidatta, edited by Vaidya Yadav ji Trikam ji Acharya, Chaukhambha Surbharti Prakashan,Varanasi, reprint, Siddhisthana, 2008; 12/54.

42. Pert, Candace B. Molecules of Emotion: Why You Feel the Way You Feel. 1st Touchstone ed. New York: Touchstone, 1999.